
This episode explores the challenges of predicting toxicity in drugs, particularly when it comes to rare liver diseases. Dr. Jake Chen's research highlights the limitations of current AI models and proposes a new framework for predicting toxicity. The discussion delves into the complexities of human biology and the need for a more nuanced approach to drug development.
Join the discussion — sign in to leave a comment.
Log in to comment